Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals.

Drugs · 2022 · PMC9152838 · PMID 35639288

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The primary endpoint of change in QMG, assessed only after the first period, showed a decrease that did not reach statistical significance, perhaps because the duration of SC treatment was too short.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.